PDT Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,484
Closed -$958K 707
2024
Q3
$958K Sell
3,484
-10,800
-76% -$2.81M 0.08% 374
2024
Q2
$3.47M Buy
+14,284
New +$2.26M 0.33% 86
2024
Q1
Sell
-5,916
Closed -$1.13M 621
2023
Q4
$1.13M Sell
5,916
-8,551
-59% -$1.46M 0.13% 268
2023
Q3
$2.56M Buy
+14,467
New +$2.76M 0.32% 91
2021
Q1
Sell
-8,800
Closed -$1.14M 761
2020
Q4
$1.14M Buy
+8,800
New +$1.18M 0.08% 303
2020
Q2
Sell
-68,313
Closed -$7.44M 659
2020
Q1
$7.44M Sell
68,313
-48,700
-42% -$5.62M 0.59% 50
2019
Q4
$13.5M Sell
117,013
-5,100
-4% -$508K 0.83% 6
2019
Q3
$9.82M Sell
122,113
-16,687
-12% -$1.32M 0.58% 38
2019
Q2
$10.1M Buy
138,800
+63,722
+85% +$4.89M 0.6% 41
2019
Q1
$7.02M Buy
+75,078
New +$6.28M 0.4% 92
2017
Q4
Sell
-237,626
Closed -$27.9M 530
2017
Q3
$27.9M Sell
237,626
-57,474
-19% -$4.91M 0.92% 3
2017
Q2
$23.5M Buy
+295,100
New +$18.9M 0.95% 19
2014
Q1
Sell
-5,804
Closed -$373K 1291
2013
Q4
$373K Buy
+5,804
New +$346K 0.04% 486

Other funds holding ALNY